JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Protokół
  • Dyskusje
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

This technique demonstrates an efficient way to prepare replication-defective retroviral stocks encoding a human oncogene, and subsequently used for induction of myeloproliferative disease in the mouse model.

Streszczenie

Our lab studies human myeloproliferative diseases induced by such oncogenes as Bcr-Abl or growth factor receptor-derived oncogenes (ZNF198-FGFR1, Bcr-PDGFRα, etc.). We are able to model and study a human-like disease in our mouse model, by transplanting bone marrow cells previously infected with a retrovirus expressing the oncogene of interest. Replication-defective retrovirus encoding a human oncogene and a marker (GFP, RFP, antibiotic resistance gene, etc.) is produced by a transient transfection protocol using 293T cells, a human renal epithelial cell line transformed by the adenovirus E1A gene product. 293 cells have the unusual property of being highly transfectable by calcium phosphate (CaPO4), with up to 50-80% transfection efficiency readily attainable. Here, we co-transfect 293 cells with a retroviral vector expressing the oncogene of interest and a plasmid that expresses the gag-pol-env packaging functions, such as the single-genome packaging constructs kat or pCL, in this case the EcoPak plasmid. The initial transfection is further improved by use of chloroquine. Stocks of ecotropic virus, collected as culture supernatant 48 hrs. post-transfection, can be stored at -80°C and used for infection of cell-lines in view of transformation and in vitro studies, or primary cells such as mouse bone marrow cells, that can then be used for transplant in our mouse model.

Protokół

  1. The evening before transformation, plate 293T cells at 3-5x106 cells/6 cm tissue cultureplate.

    Note: We use 293T cells for their ease of transfection and efficacyas virus producing cells. These cells are deficient in packaging the virus unless a helper plasmid is introduced.

  2. The first morning, gently remove medium and replace with 4 ml 293T cell med containing 25 mM Chloroquine. Put in incubator for 1 hr.

    Note: the plate should be about 80% confluent.

  3. Meanwhile, prepare virus-making mixture for 2 plates at a time, in 5 ml tubes:
    1. 2 x 10 mg retroviral plasmid construct
    2. 2 x 5 mg packaging construct (EcoPak),
    3. 2 x 62 ml CaCl
    4. complete to 1 ml with sterile ddH2O

      Note: While the retroviral plasmid encodes the oncogene of interest and a marker, EcoPak encodes gag-pol-env. Together with the 293T cells, they will produce an ecotropic retrovirus(RV) specific for mouse cells, but not infective for human cells. Both Chloroquine and CaCl2 have been shown to increase transfection efficiency.

  4. Add 1ml of 2x sterileHBS drop-wise to the mixture, while gently vortexing the tube.
  5. Immediately add this solution to 2 plates, 1 ml each, gently, drop by drop.
  6. Put in incubator for 7 to 11 hrs.
  7. In the evening (7 to 11 hrs. later), gently remove medium, and very gently replace with 5 ml fresh 293T medium. Put in incubator until noon, the next day.

    Note: this step is important, as you need to take off the chloroquine from the cells. If kept for extended periods of time, chloroquine is toxic. The solution in the plates looks fuzzy, due to a very fine, dust-like precipitation of the transfection mixture.


    Note: It is important to do all media changes with extreme gentleness, as the cells have been sensitized by the chloroquine, and can easily detach from the plate.

  8. Next day, 18 to 24 hrs. before retrieving the virus (around noon), gently remove medium, and very gently replace with 3 ml fresh 293T medium. Replace in incubator O/N.
  9. The third morning (18 to 24 hrs. later), gently suck up the medium form the plates with a 10 ml syringe fitted with an 18 G needle. This supernatant contains the retrovirus.
  10. Change the needle to a 45 mm syringe filter, invert syringe several times to mix the solution well, pass supernatant through filter, and aliquot in cryotubes

    Note: Alternatively, if you are making 3+ plates of virus, pool all supernatants of the same virus into a 50 ml conical tube. Mix well, then aliquot supernatants containing the retrovirus in cryotubes by filtering.

  11. The tubes containing the virus-full supernatants are kept in -80°C until used.

Access restricted. Please log in or start a trial to view this content.

Dyskusje

Four critical points will assure the success of a good viral stock:
   

  1. The 293T producing cells have to be very healthy, meaning they have been split on a very regular schedule, were never overgrown, and are plated at the optimized density of 3.5-5 million per 6 cm tissue culture plate, so that they reach a density of 80% of the plate on the morning of the transfection. 
  2. Addition of chloroquine improves transfection efficiency and subsequent virus titer, about 3- ...

Access restricted. Please log in or start a trial to view this content.

Materiały

NameCompanyCatalog NumberComments
293T cellscell-lineSplit 1:3 to 1:4 every 3 days, otherwise they will tend to clump with replating and will not transfect as well.
293T cell mediumDMEM/hi-glu + 10 % FBS + 1% Pen/Strep + 1% L-Glutamine (1% NEAA, optional). We obtain our tissue culture slutions from CellGro.
coding DNA plasmidTwice purified by CsCl. MSCV backbone, encoding oncogene and marker of choice (Neo, GFP, etc.)
EcoPakalso called pMCV-Ecopac: ecotropic packaging plasmid, encoding gag-pol-env
2x HBSFor 500 ml: 8.0 g NaCl+ 0.37 g KCl + 106.5 mg Na2HPO4 (anhydrous; 201.1 mg if 7xH2O) + 1.0 g dextrose (D-glucose) + 5.0 g HEPES powder. Dissolve in 450 ml dH2O (milli-Q), adjust pH to 7.05 with NaOH, then complete to 500 ml with dH2O. Sterile filter thru 0.45 μ filter. Store at room temperature, with the cap on tight.
2M CaCl2Sigma-Aldrich
miliQ H2Osterile-filtered
Chloroquine1000x stock is 25 mM in PBS- (w/o Ca2+/Mg2+), stored at -20C. Add fresh to the medium when needed.
6 cm platesfor tissue culture
Incubatorfor tissue culture. Set at 37C, 10% CO2.
10 cc sterile syringesSterile. One per virus type.
18G needlessingle use, one per virus type.
45 um syringe filters
5 ml plastic tubesSterile, to mix transfection solution, for up to 2 plates at a time (2 ml). We use Falcon tubes.
50 ml conical tubes
cryovials2 and 4 ml, for virus aliquots.

All reagents used in the transfection must be sterile-filtered (CaCl2, 2x HBS, miliQ H2O) and kept sterile.

Odniesienia

  1. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., Calos, M. P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol. 7, 379-387 (1987).
  2. Cherry, S. R., Biniszkiewicz, D., van Parijs, L., Baltimore, D., Jaenisch, R. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol. 20, 7419-7426 (2000).
  3. Finer, M. H., Dull, T. J., Qin, L., Farson, D., Roberts, M. kat: A high-efficiency retroviral transduction system for primary human T lymphocytes. Blood. 83, 43-50 (1994).
  4. Naviaux, R. K., Costanzi, E., Haas, M., Verma, I. M. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol. 70, 5701-5705 (1996).
  5. Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., Baltimore, D. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 92, 3780-3792 (1998).
  6. Pear, W. S., Nolan, G. P., Scott, M. L., Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA. 90, 8392-8396 (1993).
  7. Stocking, C., Kollek, R., Bergholz, U., Ostertag, W. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Proc Natl Acad Sci USA. 82, 5746-5750 (1985).
  8. Van Etten, R. A. Models of chronic myeloid leukemia. Curr Oncol Rep. 3, 228-237 (2001).
  9. Van Etten, R. A. Studying the pathogenesis of BCR-ABL+ leukemia in mice. Oncogene. 21, 8643-8651 (2002).

Access restricted. Please log in or start a trial to view this content.

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Replication defective RetrovirusTransient Transfection293T CellsHuman Myeloproliferative DiseasesOncogenesBcr AblGrowth Factor Receptor derived OncogenesZNF198 FGFR1Bcr PDGFRMouse ModelBone Marrow CellsRetroviral VectorGag pol env Packaging FunctionsCalcium Phosphate TransfectionChloroquineEcotropic VirusCulture SupernatantCell linesTransformation StudiesIn Vitro StudiesPrimary CellsMouse Model

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone